Carisma Therapeutics

Carisma Therapeutics

Biotechnology Research

Philadelphia, Pennsylvania 14,456 followers

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

About us

Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Philadelphia, Pennsylvania
Type
Public Company
Founded
2016

Locations

  • Primary

    3675 Market St, Ste 401

    Philadelphia, Pennsylvania 19104, US

    Get directions

Employees at Carisma Therapeutics

Updates

Similar pages

Browse jobs

Funding

Carisma Therapeutics 7 total rounds

Last Round

Series C

US$ 30.0M

See more info on crunchbase